Louisa A Messenger1, Robert H Gilman2, Manuela Verastegui3, Gerson Galdos-Cardenas2, Gerardo Sanchez3, Edward Valencia3, Leny Sanchez3, Edith Malaga3, Victoria R Rendell4, Malasa Jois5, Vishal Shah6, Nicole Santos7, Maria Del Carmen Abastoflor8, Carlos LaFuente8, Rony Colanzi8, Ricardo Bozo9, Caryn Bern7. 1. Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom. 2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru. 4. Department of Surgery, Duke University, Durham, North Carolina. 5. Division of Internal Medicine, Brown University, Providence, Rhode Island. 6. Department of Medicine, New York University, New York. 7. Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco. 8. Hospital Universitario Japones, Santa Cruz. 9. Hospital Municipal Camiri, Plurinational State of Bolivia.
Abstract
BACKGROUND: Congenital Trypanosoma cruzi transmission is now estimated to account for 22% of new infections, representing a significant public health problem across Latin America and internationally. Treatment during infancy is highly efficacious and well tolerated, but current assays for early detection fail to detect >50% of infected neonates, and 9-month follow-up is low. METHODS: Women who presented for delivery at 2 urban hospitals in Santa Cruz Department, Bolivia, were screened by rapid test. Specimens from infants of infected women were tested by microscopy (micromethod), quantitative PCR (qPCR), and immunoglobulin (Ig)M trypomastigote excreted-secreted antigen (TESA)-blots at birth and 1 month and by IgG serology at 6 and 9 months. RESULTS: Among 487 infants of 476 seropositive women, congenital T. cruzi infection was detected in 38 infants of 35 mothers (7.8%). In cord blood, qPCR, TESA-blot, and micromethod sensitivities/specificities were 68.6%/99.1%, 58.3%/99.1%, and 16.7%/100%, respectively. When birth and 1-month results were combined, cumulative sensitivities reached 84.2%, 73.7%, and 34.2%, respectively. Low birthweight and/or respiratory distress were reported in 11 (29%) infected infants. Infants with clinical signs had higher parasite loads and were significantly more likely to be detected by micromethod. CONCLUSIONS: The proportion of T. cruzi-infected infants with clinical signs has fallen since the 1990s, but symptomatic congenital Chagas disease still represents a significant, albeit challenging to detect, public health problem. Molecular methods could facilitate earlier diagnosis and circumvent loss to follow-up but remain logistically and economically prohibitive for routine screening in resource-limited settings.
BACKGROUND: Congenital Trypanosoma cruzi transmission is now estimated to account for 22% of new infections, representing a significant public health problem across Latin America and internationally. Treatment during infancy is highly efficacious and well tolerated, but current assays for early detection fail to detect >50% of infected neonates, and 9-month follow-up is low. METHODS: Women who presented for delivery at 2 urban hospitals in Santa Cruz Department, Bolivia, were screened by rapid test. Specimens from infants of infected women were tested by microscopy (micromethod), quantitative PCR (qPCR), and immunoglobulin (Ig)M trypomastigote excreted-secreted antigen (TESA)-blots at birth and 1 month and by IgG serology at 6 and 9 months. RESULTS: Among 487 infants of 476 seropositive women, congenital T. cruzi infection was detected in 38 infants of 35 mothers (7.8%). In cord blood, qPCR, TESA-blot, and micromethod sensitivities/specificities were 68.6%/99.1%, 58.3%/99.1%, and 16.7%/100%, respectively. When birth and 1-month results were combined, cumulative sensitivities reached 84.2%, 73.7%, and 34.2%, respectively. Low birthweight and/or respiratory distress were reported in 11 (29%) infected infants. Infants with clinical signs had higher parasite loads and were significantly more likely to be detected by micromethod. CONCLUSIONS: The proportion of T. cruzi-infected infants with clinical signs has fallen since the 1990s, but symptomatic congenital Chagas disease still represents a significant, albeit challenging to detect, public health problem. Molecular methods could facilitate earlier diagnosis and circumvent loss to follow-up but remain logistically and economically prohibitive for routine screening in resource-limited settings.
Authors: Margarita Bisio; María Elena Seidenstein; Juan M Burgos; Griselda Ballering; Marikena Risso; Rosa Pontoriero; Marcelo Moreau; Jaime Altcheh; María Susana Leguizamón; Hector Freilij; Marta Marceillac; Alejandro G Schijman Journal: Trans R Soc Trop Med Hyg Date: 2011-07-30 Impact factor: 2.184
Authors: Michelle Kaplinski; Malasa Jois; Gerson Galdos-Cardenas; Victoria R Rendell; Vishal Shah; Rose Q Do; Rachel Marcus; Melissa S Burroughs Pena; Maria del Carmen Abastoflor; Carlos LaFuente; Ricardo Bozo; Edward Valencia; Manuela Verastegui; Rony Colanzi; Robert H Gilman; Caryn Bern Journal: Clin Infect Dis Date: 2015-06-09 Impact factor: 9.079
Authors: Yagahira E Castro-Sesquen; Freddy Tinajeros; Caryn Bern; Gerson Galdos-Cardenas; Edith S Malaga; Edward Valencia Ayala; Kathryn Hjerrild; Steven J Clipman; Andrés G Lescano; Tabitha Bayangos; Walter Castillo; María Carmen Menduiña; Kawsar R Talaat; Robert H Gilman Journal: Clin Infect Dis Date: 2021-07-15 Impact factor: 9.079
Authors: Pierre Buekens; María Luisa Cafferata; Jackeline Alger; Fernando Althabe; José M Belizán; Norma Bustamante; Yves Carlier; Alvaro Ciganda; Jaime H Del Cid; Eric Dumonteil; Rubí Gamboa-León; Jorge A García; Luz Gibbons; Olga Graiff; Jesús Gurubel Maldonado; Claudia Herrera; Elizabeth Howard; Laura Susana Lara; Benjamín López; María Luisa Matute; María Jesús Ramírez-Sierra; María Cecilia Robles; Sergio Sosa-Estani; Carine Truyens; Christian Valladares; Dawn M Wesson; Concepción Zúniga Journal: Am J Trop Med Hyg Date: 2017-11-30 Impact factor: 2.345
Authors: Sassan Noazin; Jessica A Lee; Edith S Malaga; Edward Valencia Ayala; Beth J Condori; Cristian Roca; Andres G Lescano; Caryn Bern; Walter Castillo; Holger Mayta; Maria Carmen Menduiña; Manuela R Verastegui; Freddy Tinajeros; Robert H Gilman Journal: J Infect Dis Date: 2019-01-29 Impact factor: 5.226
Authors: Sarah M Bartsch; Owen J Stokes-Cawley; Pierre Buekens; Lindsey Asti; Maria Elena Bottazzi; Ulrich Strych; Patrick T Wedlock; Elizabeth A Mitgang; Sheba Meymandi; Jorge Abelardo Falcon-Lezama; Peter J Hotez; Bruce Y Lee Journal: Vaccine Date: 2020-03-12 Impact factor: 3.641
Authors: Melissa D Klein; Freddy Tinajeros; María Del Carmen Menduiña; Edith Málaga; Beth J Condori; Manuela Verástegui; Federico Urquizu; Robert H Gilman; Natalie M Bowman Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079
Authors: Leny Sanchez; Louisa A Messenger; Tapan Bhattacharyya; Robert H Gilman; Holger Mayta; Rony Colanzi; Ricardo Bozo; Manuela Verástegui; Michael A Miles; Caryn Bern Journal: Trans R Soc Trop Med Hyg Date: 2022-01-19 Impact factor: 2.455